Ultragenyx Pharmaceutical Inc. Other Liabilities, Noncurrent in USD from Q4 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Ultragenyx Pharmaceutical Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2013 to Q3 2025.
  • Ultragenyx Pharmaceutical Inc. Other Liabilities, Noncurrent for the quarter ending September 30, 2025 was $18.8M, a 16.5% increase year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)

Ultragenyx Pharmaceutical Inc. Quarterly Other Liabilities, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $18.8M +$2.65M +16.5% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $17.4M +$2.2M +14.5% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $17.1M +$2.64M +18.3% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $17.1M +$4.88M +40% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $16.1M +$5.9M +57.6% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $15.2M +$4.81M +46.2% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $14.5M +$5.22M +56.4% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $12.2M +$7.39M +153% Dec 31, 2023 10-K 2025-02-19
Q3 2023 $10.2M +$6.18M +153% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $10.4M +$6.62M +176% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $9.26M +$5.87M +173% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $4.82M +$3.82M +380% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $4.05M +$3.58M +760% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $3.77M Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $3.39M Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $1.01M -$6.34M -86.3% Dec 31, 2021 10-K 2023-02-17
Q3 2021 $471K Sep 30, 2021 10-Q 2021-11-03
Q4 2020 $7.35M Dec 31, 2020 10-Q 2021-11-03
Q4 2018 $4.76M -$360K -7.03% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $4.7M -$526K -10.1% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $4.84M -$578K -10.7% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $4.94M -$645K -11.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $5.12M -$1.27M -19.9% Dec 31, 2017 10-K 2019-02-20
Q3 2017 $5.23M -$3.62M -40.9% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $5.41M -$659K -10.9% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $5.59M +$1.11M +24.8% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $6.39M +$5.83M +1040% Dec 31, 2016 10-K 2018-02-21
Q3 2016 $8.85M +$8.21M +1295% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $6.07M +$5.39M +788% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $4.48M +$4M +837% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $561K +$56K +11.1% Dec 31, 2015 10-K 2017-02-17
Q3 2015 $634K +$101K +18.9% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 $684K +$124K +22.1% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $478K +$296K +163% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $505K +$305K +153% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $533K Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $560K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $182K Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $200K Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.